FDA Warns of Breathing Risks with Gabapentin and Pregabalin for Nerve Pain
The FDA has issued a warning about the risk of serious breathing problems linked to gabapentin and pregabalin, commonly prescribed for nerve pain, seizures, and restless legs syndrome. This risk is heightened when these drugs are combined with opioids and other CNS depressants, particularly impacting the elderly and those with respiratory conditions. New warning labels and clinical trials are mandated to address these dangers.
Health
July 29, 2024
0 Comments
by Arabella Simmons